Cargando…
Cathepsin L interacts with CDK2-AP1 as a potential predictor of prognosis in patients with breast cancer
Cathepsin L (CTSL) is a lysosomal acid cysteine protease that has been implicated in tumorigenesis and malignant progression. In the present study, the role of CTSL in tumorigenesis and prognosis of breast cancer was evaluated. The prognostic value of CTSL was analyzed using immunohistochemistry in...
Autores principales: | Wang, Zhan, Xiang, Zhen, Zhu, Ting, Chen, Juan, Zhong, Mei-Zuo, Huang, Juan, Wang, Kuan-Song, Li, Ling, Sun, Lun-Quan, Zhou, Wei-Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924096/ https://www.ncbi.nlm.nih.gov/pubmed/31897127 http://dx.doi.org/10.3892/ol.2019.11067 |
Ejemplares similares
-
Molecular characterization and determination of the biochemical properties of cathepsin L of Trichinella spiralis
por: Liu, Ruo Dan, et al.
Publicado: (2022) -
Integrated bioinformatics analysis reveals that the expression of cathepsin S is associated with lymph node metastasis and poor prognosis in papillary thyroid cancer
por: Tan, Juan, et al.
Publicado: (2018) -
The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study
por: Gormley, J A, et al.
Publicado: (2011) -
Cysteine cathepsin C: a novel potential biomarker for the diagnosis and prognosis of glioma
por: Cheng, Xingbo, et al.
Publicado: (2022) -
CDK2AP1 influences immune infiltrates and serves as a prognostic indicator for hepatocellular carcinoma
por: Che, Yibin, et al.
Publicado: (2022)